Industry reports
Editor highlights

Publication dates

All regions

Cancer Research Reports, April 2014

You might be interested in: medical equipment, therapeutics, prostate cancer, more »


 

1-20 of about 141 000 reports for Cancer
Carbohydrate Antigens Test Systems for Pancreatic Cancer - Medical Device Safety and Approval Report - Comprehensive

Carbohydrate Antigens Test Systems for Pancreatic Cancer - Medical Device Safety and Approval Report - Comprehensive

  • $ 199
  • Industry report
  • April 2014
  • by DeviceMatters

... Carbohydrate antigens test systems for pancreatic cancer - medical device safety and approval report - comprehensive the comprehensive devicematters medical device safety and approval report provides ...

Cancer Coagulation Electrosurgical Generators - Medical Device Safety and Approval Report - Comprehensive

Cancer Coagulation Electrosurgical Generators - Medical Device Safety and Approval Report - Comprehensive

  • $ 99
  • Industry report
  • April 2014
  • by DeviceMatters

... cancer coagulation electrosurgical generators - medical device safety and approval report - comprehensive the comprehensive devicematters medical device safety and approval report provides ...

Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA - Test & Patients - Worldwide

Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA - Test & Patients - Worldwide

  • $ 1 490
  • Industry report
  • April 2014
  • by Renub Research

... Is most adoptable test in developing countries as it is cheaper in comparison to pap smear test and hpv dna test.Cervical cancer test market is dominated by united states in 2013. Germany and united ...

Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014

Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... To the clinical trials on non-small cell lung cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ...

Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014

Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... To the clinical trials on metastatic breast cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary ...

Neuroendocrine Cancer Global Clinical Trials Review, H1, 2014

Neuroendocrine Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... Trials on neuroendocrine cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...

B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014

B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... Trials market, global, clinical trials by national cancer institute, 2014* 81b-cell non-hodgkin lymphoma therapeutics clinical trials market, global, clinical trials by fred hutchinson cancer research ...

Active Biotech AB (ACTI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Active Biotech AB (ACTI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2014
  • by Global Data

... The development and commercialization of pharmaceuticals in the field of autoimmune/inflammatory diseases and cancer. The company has five projects in clinical development of which three have been licensed out. Its ...

Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2014

Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... Information and data relating to the clinical trials on hormone-sensitive prostate cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...

Penile Cancer Global Clinical Trials Review, H1, 2014

Penile Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... Status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating penile cancer. This report is built using data and information sourced from ...


» Read our Company Profiles

72 Companies for Cancer

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

Cepheid

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.